Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1991 Dec;214(6):679–688. doi: 10.1097/00000658-199112000-00007

Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s.

E J Schweitzer 1, A J Matas 1, K J Gillingham 1, W D Payne 1, P F Gores 1, D L Dunn 1, D E Sutherland 1, J S Najarian 1
PMCID: PMC1358492  PMID: 1741647

Abstract

A variety of refinements in the care of kidney transplant recipients have been instituted over the past decade. The authors studied the overall impact of these refinements on kidney allograft losses at a single institution. To do this they compared the causes and rates of graft loss for primary kidney transplants in the 1970s (January 1, 1970 to December 31, 1979; n = 1012; 657 nondiabetics, 355 diabetics; 617 living donors, 395 cadaver donors) versus the 1980s (January 1, 1980 to December 31, 1989; n = 1,384; 756 nondiabetics, 628 diabetics; 740 living donors, 644 cadaver donors). Overall patient survival improved significantly, with rates at 1, 5, and 10 years of 94%, 84%, and 68% for the 1980s, compared with 86%, 69%, and 57% for the 1970s (p less than 0.001). Actuarial graft survival also improved significantly, with rates at 1, 5, and 10 years of 86%, 71%, and 52% for the 1980s, compared with 73%, 58%, and 43% for the 1970s (p less than 0.001). This improvement occurred even though there were proportionately more cadaver donors and diabetic recipients in the 1980s. For both decades combined, 24% of the lost grafts were due to chronic rejection, 18% to cardiovascular causes of death with function, 13% to infectious causes of death with function, and 11% to acute rejection. The overall gain in graft survival rates in the 1980s was principally due to fewer cases of acute rejection and fewer infectious deaths. Improvement in graft survival due to the two leading causes--chronic rejection and cardiovascular causes of death--was relatively small, if any. These data indicate that future kidney transplantation research should emphasize prevention of chronic rejection and cardiovascular death.

Full text

PDF
679

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abele R., Novick A. C., Braun W. E., Steinmuller D., Buszta C., Greenstreet R., Hinton J. Long-term results of renal transplantation in recipients with a functioning graft for 2 years. Transplantation. 1982 Nov;34(5):264–267. doi: 10.1097/00007890-198211000-00005. [DOI] [PubMed] [Google Scholar]
  2. Andres G. A., Accinni L., Hsu K. C., Penn I., Porter K. A., Rendall J. M., Seegal B. C., Starzl T. E. Human renal transplants. 3. Immunopathologic studies. Lab Invest. 1970 Jun;22(6):588–604. [PMC free article] [PubMed] [Google Scholar]
  3. Balfour H. H., Jr, Chace B. A., Stapleton J. T., Simmons R. L., Fryd D. S. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med. 1989 May 25;320(21):1381–1387. doi: 10.1056/NEJM198905253202105. [DOI] [PubMed] [Google Scholar]
  4. Brenner B. M., Meyer T. W., Hostetter T. H. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982 Sep 9;307(11):652–659. doi: 10.1056/NEJM198209093071104. [DOI] [PubMed] [Google Scholar]
  5. Canafax D. M., Simmons R. L., Sutherland D. E., Fryd D. S., Strand M. H., Ascher N. L., Payne W. D., Najarian J. S. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine. Transplant Proc. 1986 Apr;18(2 Suppl 1):192–196. [PubMed] [Google Scholar]
  6. Dlugosz B. A., Bretan P. N., Jr, Novick A. C., Steinmuller D. R., Streem S. B., Badwar K., Woodard R. M. Causes of death in kidney transplant recipients: 1970 to present. Transplant Proc. 1989 Feb;21(1 Pt 2):2168–2170. [PubMed] [Google Scholar]
  7. Feehally J., Harris K. P., Bennett S. E., Walls J. Is chronic renal transplant rejection a non-immunological phenomenon? Lancet. 1986 Aug 30;2(8505):486–488. doi: 10.1016/s0140-6736(86)90359-4. [DOI] [PubMed] [Google Scholar]
  8. Fellström B., Larsson E., Tufveson G. Strategies in chronic rejection of transplanted organs: a current view on pathogenesis, diagnosis, and treatment. Transplant Proc. 1989 Feb;21(1 Pt 2):1435–1439. [PubMed] [Google Scholar]
  9. Foster M. C., Rowe P. A., Dennis M. J., Morgan A. G., Burden R. P., Blamey R. W. Characteristics of cadaveric renal allograft recipients developing chronic rejection. Ann R Coll Surg Engl. 1990 Jan;72(1):23–26. [PMC free article] [PubMed] [Google Scholar]
  10. Foster M. C., Wenham P. W., Rowe P. A., Burden R. P., Morgan A. G., Cotton R. E., Blamey R. W. The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss. Ann R Coll Surg Engl. 1989 Jan;71(1):44–47. [PMC free article] [PubMed] [Google Scholar]
  11. Fox B. C., Sollinger H. W., Belzer F. O., Maki D. G. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med. 1990 Sep;89(3):255–274. doi: 10.1016/0002-9343(90)90337-d. [DOI] [PubMed] [Google Scholar]
  12. GEHAN E. A. A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. Biometrika. 1965 Jun;52:203–223. [PubMed] [Google Scholar]
  13. Gore S. M., Oldham J. A. Randomized trials of high-versus-low-dose steroids in renal transplantation. Does the evidence favor a consensus? Transplantation. 1986 Mar;41(3):319–327. doi: 10.1097/00007890-198603000-00008. [DOI] [PubMed] [Google Scholar]
  14. Hostetter T. H., Rennke H. G., Brenner B. M. Compensatory renal hemodynamic injury: a final common pathway of residual nephron destruction. Am J Kidney Dis. 1982 Mar;1(5):310–314. doi: 10.1016/s0272-6386(82)80032-2. [DOI] [PubMed] [Google Scholar]
  15. Kahan B. D., Kerman R. H., Wideman C. A., Flechner S. M., Jarowenko M., Van Buren C. T. Impact of cyclosporine on renal transplant practice at the University of Texas Medical School at Houston. Am J Kidney Dis. 1985 Jun;5(6):288–295. doi: 10.1016/s0272-6386(85)80157-8. [DOI] [PubMed] [Google Scholar]
  16. Kaufman D. B., Kim T. H., Slavin S., Najarian J. S., Sutherland D. E. Long-term clinical studies of high-risk renal retransplant recipients given total lymphoid irradiation. Transplant Proc. 1989 Feb;21(1 Pt 2):1798–1799. [PubMed] [Google Scholar]
  17. Kirkman R. L., Strom T. B., Weir M. R., Tilney N. L. Late mortality and morbidity in recipients of long-term renal allografts. Transplantation. 1982 Dec;34(6):347–351. doi: 10.1097/00007890-198212000-00007. [DOI] [PubMed] [Google Scholar]
  18. Matas A. J., Simmons R. L., Buselmeier T. J., Najarian J. S., Kjellstrand C. M. Lethal complications of bilateral nephrectomy and splenectomy in hemodialyzed patients. Am J Surg. 1975 Jun;129(6):616–620. doi: 10.1016/0002-9610(75)90332-3. [DOI] [PubMed] [Google Scholar]
  19. Najarian J. S., Ferguson R. M., Sutherland D. E., Slavin S., Kim T., Kersey J., Simmons R. S. Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies. Ann Surg. 1982 Oct;196(4):442–452. doi: 10.1097/00000658-198210000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Najarian J. S., Fryd D. S., Strand M., Canafax D. M., Ascher N. L., Payne W. D., Simmons R. L., Sutherland D. E. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg. 1985 Feb;201(2):142–157. doi: 10.1097/00000658-198502000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Najarian J. S., Simmons R. L., Condie R. M., Thompson E. J., Fryd D. S., Howard R. J., Matas A. J., Sutherland D. E., Ferguson R. M., Schmidtke J. R. Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg. 1976 Sep;184(3):352–368. doi: 10.1097/00000658-197609000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. PORTER K. A., PEART W. S., KENYON J. R., JOSEPH N. H., HOEHN R. J., CALNE R. Y. REJECTION OF KIDNEY HOMOTRANSPLANTS. Ann N Y Acad Sci. 1964 Nov 30;120:472–495. doi: 10.1111/j.1749-6632.1964.tb34746.x. [DOI] [PubMed] [Google Scholar]
  23. Peters C., Peterson P., Marabella P., Simmons R. L., Najarian J. S. Continuous sulfa prophylaxis for urinary tract infection in renal transplant recipients. Am J Surg. 1983 Nov;146(5):589–593. doi: 10.1016/0002-9610(83)90294-5. [DOI] [PubMed] [Google Scholar]
  24. Petersen V. P., Olsen T. S., Kissmeyer-Nielsen F., Bohman S. O., Hansen H. E., Hansen E. S., Skov P. E., Solling K. Late failure or human renal transplants. An analysis of transplant disease and graft failure among 125 recipients surviving for one to eight years. Medicine (Baltimore) 1975 Jan;54(1):45–71. [PubMed] [Google Scholar]
  25. Pfaff W. W., Fennell R. S., Howard R. J., Ireland J. F., Scornik J. C. Planned random donor blood transfusion in preparation for transplantation. Sensitization and graft survival. Transplantation. 1984 Dec;38(6):701–703. doi: 10.1097/00007890-198412000-00030. [DOI] [PubMed] [Google Scholar]
  26. Popovtzer M. M., Pinnggera W., Katz F. H., Corman J. L., Roninette J., Lanois B., Haglrimson C. G., Starzel T. E. Variations in arterial blood pressure after kidney transplantation. Relation to renal function, plasma renin activity, and the dose of prednisone. Circulation. 1973 Jun;47(6):1297–1305. doi: 10.1161/01.cir.47.6.1297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rosansky S. J., Sugimoto T. An analysis of the United States renal transplant patient population and organ survival characteristics: 1977 to 1980. Kidney Int. 1982 Dec;22(6):685–692. doi: 10.1038/ki.1982.230. [DOI] [PubMed] [Google Scholar]
  28. Rosenblum N. D., Harmon W. E., Levey R. H. Treatment of chronic renal allograft rejection with cyclosporine and prednisone. Transplantation. 1988 Jan;45(1):232–234. doi: 10.1097/00007890-198801000-00049. [DOI] [PubMed] [Google Scholar]
  29. Salvatierra O., Jr, Feduska N. J., Cochrum K. C., Najarian J. S., Kountz S. L., Belzer F. O. The impact of 1,000 renal transplants at one center. Ann Surg. 1977 Oct;186(4):424–435. doi: 10.1097/00000658-197710000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Schmidt J. A., Mizel S. B., Cohen D., Green I. Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol. 1982 May;128(5):2177–2182. [PubMed] [Google Scholar]
  31. Strom T. B. The improving utility of renal transplantation in the management of end-stage renal disease. Am J Med. 1982 Jul;73(1):105–124. doi: 10.1016/0002-9343(82)90937-8. [DOI] [PubMed] [Google Scholar]
  32. Sutherland D. E., Fryd D. S., So S. K., Bentley F. R., Ascher N. L., Simmons R. L., Najarian J. S. Long-term effect of splenectomy versus no splenectomy in renal transplant patients. Reanalysis of a randomized prospective study. Transplantation. 1984 Dec;38(6):619–624. doi: 10.1097/00007890-198412000-00015. [DOI] [PubMed] [Google Scholar]
  33. Sweny P., Wheeler D. C., Lui S. F., Amin N. S., Barradas M. A., Jeremy J. Y., Mikhailidis D. P., Varghese Z., Fernando O. N., Moorhead J. F. Dietary fish oil supplements preserve renal function in renal transplant recipients with chronic vascular rejection. Nephrol Dial Transplant. 1989;4(12):1070–1075. [PubMed] [Google Scholar]
  34. Tilney N. L., Strom T. B., Vineyard G. C., Merrill J. P. Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med. 1978 Dec 14;299(24):1321–1325. doi: 10.1056/NEJM197812142992401. [DOI] [PubMed] [Google Scholar]
  35. Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies. Collaborative DHPG Treatment Study Group. N Engl J Med. 1986 Mar 27;314(13):801–805. doi: 10.1056/NEJM198603273141301. [DOI] [PubMed] [Google Scholar]
  36. Washer G. F., Schröter G. P., Starzl T. E., Weil R., 3rd Causes of death after kidney transplantation. JAMA. 1983 Jul 1;250(1):49–54. [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES